LCZ696 (angiotensin-neprilysin inhibition): the new kid on the heart failure block?
about
Small-molecule AT2 receptor agonists.A Review of New Pharmacologic Treatments for Patients With Chronic Heart Failure With Reduced Ejection Fraction.Vascular Impairment of Epineurial Arterioles of the Sciatic Nerve: Implications for Diabetic Peripheral Neuropathy.Potential beneficial effects of sacubitril-valsartan in renal disease: a new field for a new drug.Recent Advances in Treatment of Coronary Artery Disease: Role of Science and Technology.Combined Angiotensin Receptor-Neprilysin Inhibitors Improve Cardiac and Vascular Function Via Increased NO Bioavailability in Heart Failure.
P2860
LCZ696 (angiotensin-neprilysin inhibition): the new kid on the heart failure block?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
LCZ696 (angiotensin-neprilysin inhibition): the new kid on the heart failure block?
@en
type
label
LCZ696 (angiotensin-neprilysin inhibition): the new kid on the heart failure block?
@en
prefLabel
LCZ696 (angiotensin-neprilysin inhibition): the new kid on the heart failure block?
@en
P2093
P2860
P356
P1476
LCZ696 (angiotensin-neprilysin inhibition): the new kid on the heart failure block?
@en
P2093
Antony Q Pham
Brittany Gallagher
Yesha Patel
P2860
P304
P356
10.1177/0897190014568675
P577
2015-04-01T00:00:00Z